Since IDH2p.R140Q is the most common IDH mutation seen in patients with AML [4], we predicted that the combination of these two mutations would lead to AML, and generated Idh2R140Q transgenic mice that were crossed with NHD13 transgenic mice to test this hypothesis. Here, IDH1 is linked to acute myeloid leukemia.